Meng Zhang

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression

C. Liang, Jialin Meng, Chawnshang Chang, 2021, Cell Death & Disease.

Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death

Chawnshang Chang, Yin Sun, Bosen You, 2021, Cell death & disease.